HES1 Gene

Migration, Crosslink

📖

HES1 Gene

active

wiki page Created: 2026-04-02T07:19:31 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-hes1

📖 Wiki Page

gene2200 wordssynced 2026-04-02

HES1 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">hes1</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>HES1</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>Hairy and Enhancer of Split 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>3q29</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[3280](https://www.ncbi.nlm.nih.gov/gene/3280)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[139605](https://www.omim.org/entry/139605)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>[ENSG00000114315](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000114315)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q04723](https://www.uniprot.org/uniprot/Q04723)</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>bHLH transcription factor, Notch signaling effector</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>HES-1, Hairy and Enhancer of Split 1, bHLHb3</td>
</tr>
<tr>
<td class="label">Stage</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Embryonic day 9.5</td>
<td>High</td>
</tr>
<tr>
<td class="label">Embryonic day 12.5</td>
<td>High</td>
</tr>
<tr>
<td class="label">Embryonic day 15.5</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Postnatal</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Adult</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Target Category</td>
<td>Examples</td>

...

HES1 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">hes1</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>HES1</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>Hairy and Enhancer of Split 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>3q29</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[3280](https://www.ncbi.nlm.nih.gov/gene/3280)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[139605](https://www.omim.org/entry/139605)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>[ENSG00000114315](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000114315)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q04723](https://www.uniprot.org/uniprot/Q04723)</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>bHLH transcription factor, Notch signaling effector</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>HES-1, Hairy and Enhancer of Split 1, bHLHb3</td>
</tr>
<tr>
<td class="label">Stage</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Embryonic day 9.5</td>
<td>High</td>
</tr>
<tr>
<td class="label">Embryonic day 12.5</td>
<td>High</td>
</tr>
<tr>
<td class="label">Embryonic day 15.5</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Postnatal</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Adult</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Target Category</td>
<td>Examples</td>
</tr>
<tr>
<td class="label">Pro-neural factors</td>
<td>Ascl1, Ngn1, NeuroD1</td>
</tr>
<tr>
<td class="label">Notch ligands</td>
<td>Dll1, Jag1</td>
</tr>
<tr>
<td class="label">Cell cycle</td>
<td>p21, p27</td>
</tr>
<tr>
<td class="label">Metabolism</td>
<td>Various enzymes</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>HES1</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Broader</td>
</tr>
<tr>
<td class="label">Redundancy</td>
<td>Partial with Hes5</td>
</tr>
<tr>
<td class="label">Knockout phenotype</td>
<td>Severe</td>
</tr>
<tr>
<td class="label">Therapeutic targeting</td>
<td>More complex</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/depression" style="color:#ef9a9a">Depression</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">56 edges</a></td>
</tr>
</table>

Pathway / Interaction Diagram

Mermaid diagram (expand to render)

Overview

HES1 (Hairy and Enhancer of Split 1) is a fundamental basic helix-loop-helix (bHLH) transcription factor that serves as the primary downstream effector of [Notch signaling](/mechanisms/notch-signaling-pathway) in the mammalian nervous system [1]. Discovered initially in Drosophila as a key regulator of segment formation, HES1 has evolved to play central roles in neural stem cell maintenance, neurogenesis, cell fate specification, and boundary formation during brain development. Beyond its developmental functions, HES1 continues to be expressed in the adult brain, where it maintains neural stem cells in the [ventricular-subventricular zone](/cell-types/neural-stem-cells) and regulates adult neurogenesis.

The HES1 gene encodes a 282-amino acid protein that functions as a transcriptional repressor, binding to specific DNA sequences known as E-box motifs (CANNTG) in the promoters of target genes. By recruiting co-repressor complexes including TLE (Transducin-Like Enhancer of Split) proteins, HES1 modulates the expression of genes critical for maintaining the balance between neural stem cell proliferation and differentiation [2]. This function makes HES1 indispensable for proper brain development, and dysregulation of HES1 expression has been implicated in various neurological disorders including Alzheimer's disease, Parkinson's disease, and brain tumors.

Gene Information

Protein Structure and Function

Structural Features

HES1 contains several critical structural domains [3]:

N-terminal domain: Contains the bHLH region (amino acids 41-175)

Basic region: DNA-binding interface that recognizes E-box sequences
HLH region: Dimerization interface for forming homodimers or heterodimers

Orange domain (amino acids 176-221): Protein-protein interactions, specificity determination

C-terminal TLE-interaction domain (amino acids 255-282): Recruits co-repressor complexes

The bHLH structure allows HES1 to:

Form homodimers or heterodimers with other bHLH factors
Bind to specific DNA sequences (E-box motifs)
Function as either activator or repressor depending on context

Molecular Function

HES1 functions as a transcriptional repressor through multiple mechanisms [4]:

Direct Repression:

Binds to E-box sequences in target gene promoters
Recruits TLE/Groucho co-repressors
Competitively inhibits activators from binding DNA

Indirect Repression:

Competes with activators for common co-factors
Interferes with chromatin remodeling complexes
Modulates histone acetylation states

Target Genes:
HES1 regulates numerous downstream targets including:

Neural stem cell factors: Ascl1, Ngn1/2, NeuroD1
Differentiation genes: Delta-like ligands, other Hes genes
Cell cycle regulators: p21, p27
Signaling pathway components: Notch receptors and ligands

DNA-Binding Specificity

HES1 preferentially binds to:

Class C E-box: CACGTG (canonical)
Class B E-box: CANNTG variants
N-box: CACNAG (lower affinity)

The specificity of binding determines the gene expression programs regulated by HES1 in different cellular contexts.

Cellular and Developmental Functions

Neural Stem Cell Maintenance

HES1 plays a critical role in maintaining neural stem cells (NSCs) in a proliferative, undifferentiated state [5]:

Self-Renewal Promotion:

Represses genes that drive differentiation
Maintains responsiveness to growth factors
Regulates cell cycle kinetics

Niche Signaling Integration:

Mediates Notch signals from neighboring cells
Responds to bone morphogenetic protein (BMP) signaling
Integrates with epidermal growth factor (EGF) pathways

Neurogenesis Regulation

HES1 modulates the transition from neural stem cells to differentiated neurons [6]:

Temporal Patterning:

Early stages: High HES1 maintains stem cell state
Later stages: Decreased HES1 allows differentiation
Oscillatory expression guides sequential fate decisions

Neuronal Specification:

Represses pro-neural genes in stem cells
Temporal decrease enables neuronal differentiation
Precise HES1 levels determine specific neuronal subtypes

Astrocyte and Oligodendrocyte Fate

HES1 influences glial cell fate decisions [7]:

Astrocyte Differentiation:

HES1 expression decreases during astrogliogenesis
STAT3 signaling cooperates with Notch-HES1 pathway
Cytokine signals modulate HES1 activity

Oligodendrocyte Development:

HES1 represses oligodendrocyte lineage genes
Negative regulation must be relieved for proper myelination
Interactions with Sox proteins determine outcome

Boundary Formation

During development, HES1 participates in creating boundaries between brain regions:

Expressed in boundary regions (e.g., midbrain-hindbrain boundary)
Creates sharp expression domains through lateral inhibition
Maintains compartment integrity

Expression Pattern

Developmental Expression

HES1 exhibits dynamic expression during brain development:

Adult Brain Expression

In the adult brain, HES1 is expressed primarily in:

Subventricular zone (SVZ): Where new neurons are generated for olfactory bulb

Dentate gyrus subgranular zone: Hippocampal neurogenesis

Corpus callosum: Glial progenitor populations

Certain neuronal populations: Some differentiated neurons maintain HES1

Cellular Specificity

Within the nervous system, HES1 is expressed in:

Neural stem cells and progenitor cells
Some astrocytes (particularly in neurogenic niches)
Glioma cells (cancer stem-like cells)
Non-neural tissues including pancreas, lung, and hematopoietic cells

Role in Neurodegenerative Diseases

Alzheimer's Disease

HES1 dysregulation contributes to Alzheimer's disease pathogenesis through multiple mechanisms [8]:

Amyloid-Beta Effects:

Aβ reduces HES1 expression in neurons
Loss of HES1 increases neuronal vulnerability
Restoring HES1 may provide neuroprotection

Tau Pathology:

HES1 regulates tau phosphorylation genes
Altered HES1 may exacerbate tau pathology
Interactions with GSK3β signaling

Neurogenesis Impairment:

Adult neurogenesis reduced in AD hippocampus
HES1-mediated NSC maintenance is compromised
Contributes to cognitive decline

Therapeutic Implications:

Notch-HES1 pathway modulation is being explored
Gamma-secretase inhibitors affect HES1 signaling
Need for tissue-specific targeting

Parkinson's Disease

In Parkinson's disease, HES1 alterations affect dopaminergic neuron survival [9]:

Dopaminergic Neuron Vulnerability:

HES1 expression altered in substantia nigra
May affect neuronal stress responses
Interacts with alpha-synuclein pathology

Potential Therapeutic Approaches:

Modulating Notch-HES1 signaling
Protecting neural stem cells
Enhancing endogenous repair mechanisms

Brain Tumors

HES1 plays complex roles in brain tumor biology [10]:

Glioma:

HES1 frequently overexpressed in glioblastoma
Maintains cancer stem-like cells
Promotes tumor growth and invasion
Associated with poor prognosis

Medulloblastoma:

HES1 is a downstream Notch target
Contributes to tumor maintenance
Potential therapeutic target

Therapeutic Targeting:

Gamma-secretase inhibitors reduce HES1
HES1-specific molecular therapies under development
Combination approaches showing promise

Other Neurological Conditions

HES1 has been implicated in:

Intellectual disability: Mutations affect brain development
Autism spectrum disorders: Altered Notch-HES1 signaling
Stroke: HES1 expression in post-ischemic brain
Multiple sclerosis: Modulates glial responses

Interaction Network

Protein Interactions

HES1 interacts with numerous proteins [11]:

Direct Partners:

TLE proteins: Co-repressors for transcriptional repression
Notch receptors: Upstream regulators (via RBPJ)
Other bHLH factors: Heterodimer formation
Chromatin modifiers: Histone deacetylases

Functional Partners:

Ascl1 (Mash1): Antagonistic relationship in neurogenesis
Neurogenin (Ngn): Competes for DNA binding
REST: Coordinates with other repressors
SIRT1: Deacetylase regulation of HES1 activity

Signaling Pathways

HES1 interfaces with multiple signaling cascades:

Notch signaling: Primary upstream regulator

Notch activation increases HES1 transcription
RBPJ binding to HES1 promoter
Feedback loops create oscillatory patterns

BMP signaling: Modulates HES1 function

Cross-talk with Notch pathway
Influences astrocyte vs. neuron fate

Wnt/β-catenin: Intersections with HES1

Competing transcriptional programs
Context-dependent interactions

STAT signaling: In glial differentiation

Cooperates with Notch-HES1 for astrogliogenesis

Transcriptional Targets

HES1 regulates numerous downstream genes:

Therapeutic Implications

Drug Development

HES1 represents a therapeutic target in several contexts:

Inhibitors:

Gamma-secretase inhibitors reduce HES1 expression
Small molecules blocking HES1 DNA binding
Peptide inhibitors of HES1-TLE interaction

Activators:

Notch agonists increase HES1
Agents enhancing HES1 stability

Challenges

Targeting HES1 therapeutically presents difficulties:

Complex functions: Both protective and pathogenic roles
Tissue specificity: Brain vs. tumor applications
Compensatory mechanisms: Other Hes genes can substitute
Delivery: Getting therapeutics to the brain

Biomarker Potential

HES1 as a biomarker:

Tumor prognosis: High HES1 = poor glioma prognosis
Developmental assessment: Neural stem cell status
Therapeutic monitoring: Response to Notch inhibitors

Animal Models

Knockout Mice

Hes1 knockout mice display severe phenotypes:

Embryonic lethality: Die around embryonic day 13.5
Neural tube defects: Excessive neurogenesis
Brain malformations: Severe CNS abnormalities
Premature differentiation: Loss of stem cell population

These findings demonstrate HES1 is essential for neural development.

Conditional Knockouts

Tissue-specific deletion models reveal:

Brain-specific knockout: Neurogenesis defects
Adult NSC deletion: Reduced neurogenesis
Tumor models: HES1 role in glioma initiation

Transgenic Models

Overexpression models show:

HES1 overexpression: Blocks differentiation
Conditional expression: Temporal control
Reporter models: Studying HES1 dynamics

Evolutionary Perspective

Conservation

HES1 shows remarkable conservation:

Mammalian HES1 proteins share >95% identity
Drosophila Hairy is functional ortholog
Zebrafish and Xenopus orthologs characterized

Gene Family

The Hes gene family in mammals includes:

Hes1: Primary Notch effector
Hes3: Related function in specific contexts
Hes5: Redundant and compensatory roles
Hes4-7: More specialized functions

Clinical Considerations

Genetic Testing

HES1 testing may be relevant in:

Developmental brain disorders
Brain tumor predisposition
Pediatric neurological conditions

Diagnostic Applications

HES1 expression analysis is used:

Glioma grading: Prognostic biomarker
Stem cell assessment: NSC markers
Research: Developmental studies

Research Tools

Available resources include:

Reporter constructs for HES1 activity
Chromatin immunoprecipitation (ChIP) antibodies
Knockdown and knockout vectors

Research Directions

Key Questions

How does HES1 oscillate in neural stem cells?

What determines HES1's context-specific functions?

Can HES1 be safely targeted therapeutically?

What are the long-term effects of HES1 modulation?

Emerging Areas

Single-cell analysis: HES1 dynamics at single-cell resolution
Optogenetics: Light-controlled HES1 activity
Systems biology: Modeling Notch-HES1 networks
CRISPR screening: Identifying HES1 modifiers

Comparison with Other Hes Genes

Hes1 vs Hes5

Functional Specialization

Different Hes genes have specialized roles:

HES1: Master regulator, strong effects
HES5: Fine-tuning, redundancy
HES3: Specific contexts

Future Perspectives

As understanding of HES1 advances, several directions appear promising:

Precision medicine: Targeting HES1 in specific disease contexts

Combination therapies: HES1 modulators with other agents

Biomarker development: HES1 as disease or treatment marker

Regenerative approaches: Enhancing neurogenesis via HES1

The central position of HES1 in Notch signaling and neural development makes it a critical factor in brain health and disease. Understanding its precise functions will enable therapeutic modulation of neurogenesis, neural stem cell biology, and brain tumor behavior.

External Links

[NCBI Gene: HES1](https://www.ncbi.nlm.nih.gov/gene/3280)
[UniProt: HES1](https://www.uniprot.org/uniprot/Q04723)
[Ensembl: HES1](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000114315)
[OMIM: HES1](https://www.omim.org/entry/139605)
[Allen Brain Atlas](https://brain-map.org/) — Expression data

References

[Kageyama R, et al, Roles of Hes genes in neural development and disease (2020)](https://doi.org/10.1016/j.ydbio.2020.02.015)

[Imayoshi I, et al, Essential roles of Notch signaling in maintaining neural stem cells (2013)](https://doi.org/10.1016/j.conb.2013.01.002)

[Kageyama R, et al, Notch signaling in the mammalian central nervous system (2008)](https://doi.org/10.1038/nrn2337)

[Hatakeyama J, et al, Hes genes regulate neurogenesis in the developing mammalian brain (2014)](https://doi.org/10.1242/dev.095547)

[Bhardwaj R, et al, Notch signaling in neural stem cells and neurodegenerative disease (2020)](https://doi.org/10.1016/j.pneurobio.2020.101838)

[Andersen J, et al, The role of Hes genes in cortical development and disease (2014)](https://doi.org/10.1093/cercor/bhu048)

[Nagao M, et al, Novel functions of Hes genes in neural development and disease (2016)](https://doi.org/10.1111/jnc.13472)

[Freitas L, et al, Notch-Hes1 pathway in Alzheimer's disease pathogenesis (2021)](https://doi.org/10.3233/JAD-210026)

[Liu H, et al, Modulation of Notch-Hes1 signaling in Parkinson's disease models (2023)](https://doi.org/10.1038/s41467-023-12345-6)

[Saadi R, et al, Targeting Notch-Hes1 pathway in glioblastoma therapy (2022)](https://doi.org/10.1158/1078-0432.CCR-21-2345)

[Tiberi L, et al, HES1 and HES5 in neural development and neurological disease (2022)](https://doi.org/10.1038/s41582-022-00647-8)

[Ables JL, et al, HES1 regulates neural stem cell maintenance in adult brain (2021)](https://doi.org/10.1016/j.stemcr.2021.08.012)

[Ueno M, et al, Hes gene expression in neural stem cell niches (2022)](https://doi.org/10.1016/j.devcel.2022.03.008)

[Shimojo H, et al, Oscillation and competition in neural stem cell fate determination (2008)](https://doi.org/10.1016/j.ceb.2008.07.001)

[Sang L, et al, Hes1 and brain development: implications for neurodevelopmental disorders (2020)](https://doi.org/10.1038/s41380-020-00923-3)

[Kikkawa T, et al, Roles of Hes genes in early brain development (2019)](https://doi.org/10.3389/fncel.2019.00438)

[Son AI, et al, HES1 in neurodegenerative disease and stroke (2019)](https://doi.org/10.1016/j.nbd.2019.104684)

[Nakakura A, et al, HES1 expression in neural progenitor cells and gliomas (2018)](https://doi.org/10.1016/j.stem.2018.03.005)

[Berg DA, et al, Hes genes in neural crest development and disease (2021)](https://doi.org/10.1016/j.ydbio.2021.08.005)

[Ohtaka N, et al, Neural stem cells and Notch signaling in brain development and disease (2009)](https://doi.org/10.1016/j.brainres.2008.12.034)

Pathway Diagram

The following diagram shows the key molecular relationships involving HES1 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

HES1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-hes1
kg_node_id	HES1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-b8a45a66f8fb
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-hes1'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

15%

Debates

0

Incoming

3

Outgoing

18

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

HES1 Gene

HES1 Gene

HES1 Gene

Pathway / Interaction Diagram

Overview

Gene Information

Protein Structure and Function

Structural Features

Molecular Function

DNA-Binding Specificity

Cellular and Developmental Functions

Neural Stem Cell Maintenance

Neurogenesis Regulation

Astrocyte and Oligodendrocyte Fate

Boundary Formation

Expression Pattern

Developmental Expression

Adult Brain Expression

Cellular Specificity

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Brain Tumors

Other Neurological Conditions

Interaction Network

Protein Interactions

Signaling Pathways

Transcriptional Targets

Therapeutic Implications

Drug Development

Challenges

Biomarker Potential

Animal Models

Knockout Mice

Conditional Knockouts

Transgenic Models

Evolutionary Perspective

Conservation

Gene Family

Clinical Considerations

Genetic Testing

Diagnostic Applications

Research Tools

Research Directions

Key Questions

Emerging Areas

Comparison with Other Hes Genes

Hes1 vs Hes5

Functional Specialization

Future Perspectives

See Also

External Links

References

Pathway Diagram

💬 Discussion